Health News carries developments as they are issued: revised clinical guidelines, regulatory decisions, safety notices, recalls and freshly published trial results. Every item names the issuing body and the document behind it, then separates what has genuinely changed for patients from what remains under consultation or review.
Reporting on guideline revisions, drug approvals, safety warnings and newly published studies affecting women's care, each traced to the source document.
Patients can now swab themselves for cervical cancer screening in a clinic, and one at-home kit is FDA-approved. Here is what each approval covers, what the evidence shows, and where national guidance still stands.
More than half of states now let Medicaid pay for a doula, but reporting on the ground shows low reimbursement and looming federal cuts are keeping the benefit out of reach for many who qualify.
A June 26, 2026 Federal Register notice placed these pregnancy blood tests in Class II with special controls, clearing a defined path for more of them.